Kestra Medical Technologies, Ltd.
$23.31
▼
-1.05%
2026-04-21 07:44:01
kestramedical.com
NMS: KMTS
Explore Kestra Medical Technologies, Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.33 B
Current Price
$23.31
52W High / Low
$30 / $13.25
Stock P/E
—
Book Value
$4.94
Dividend Yield
—
ROCE
-41.27%
ROE
-92.65%
Face Value
—
EPS
$-5.46
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
330
Beta
—
Debt / Equity
16.16
Current Ratio
7.32
Quick Ratio
6.55
Forward P/E
-8.35
Price / Sales
12.46
Enterprise Value
$798.36 M
EV / EBITDA
-5.9
EV / Revenue
9.54
Rating
Strong Buy
Target Price
$28
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Repligen Corporation | $130.14 | 150.55 | $7.4 B | — | 1.48% | 2.4% | $175.77 / $109.66 | $37.39 |
| 2. | Retractable Technologies, Inc. | $0.65 | — | $19.46 M | 1.18% | -10.73% | -15.56% | $1.14 / $0.62 | $2.48 |
| 3. | ICU Medical, Inc. | $130.58 | 4,461.76 | $3.27 B | — | 3.08% | 0.04% | $160.29 / $107 | $86.03 |
| 4. | Pro-Dex, Inc. | $53.3 | 15.38 | $174.44 M | — | 22.96% | 30.87% | $70.26 / $23.47 | $12.97 |
| 5. | The Cooper Companies, Inc. | $67.65 | 33.54 | $13.23 B | 0.02% | 6.05% | 4.87% | $89.83 / $61.78 | $42.87 |
| 6. | Regentis Biomaterials Ltd. | $2.96 | — | — | — | -181.68% | 75.07% | $8.35 / $2.8 | $0.92 |
| 7. | Intuitive Surgical, Inc. | $487.85 | 62.04 | $174.03 B | — | 15.96% | 16.69% | $603.88 / $427.84 | $50.19 |
Quarterly Results
Figures shown in M / B
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|
| Sales | 24.55 M | 22.57 M | 19.37 M | 17.23 M | 15.09 M | — | — |
| Operating Profit | -34.77 M | -31.75 M | -28.88 M | -48.21 M | -20.6 M | — | — |
| Net Profit | -34.17 M | -32.78 M | -25.83 M | -52.05 M | -21.51 M | — | — |
| EPS in Rs | -0.59 | -0.56 | -0.44 | -0.89 | -0.37 | — | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2021 | |
|---|---|---|---|---|
| Sales | 59.81 M | 27.81 M | 7.63 M | 0 M |
| Operating Profit | -106.38 M | -85.06 M | -80.42 M | -32.71 M |
| Net Profit | -113.81 M | -94.12 M | -84.24 M | -34.1 M |
| EPS in Rs | -1.95 | -1.61 | -1.44 | -0.58 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2021 | |
|---|---|---|---|---|
| Total Assets | 295.74 M | 45.95 M | 38.66 M | 30.52 M |
| Total Liabilities | 90.34 M | 255.33 M | 156.23 M | 28.76 M |
| Equity | 205.41 M | -209.38 M | -117.58 M | 1.77 M |
| Current Assets | 255.33 M | 14.91 M | 18.42 M | 26.2 M |
| Current Liabilities | 37.98 M | 32.97 M | 36.74 M | 6.61 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2021 | |
|---|---|---|---|---|
| Operating CF | -77.61 M | -72.23 M | -69.64 M | -29.89 M |
| Investing CF | -23.31 M | -12.23 M | -15.46 M | -0.33 M |
| Financing CF | 330.26 M | 77.72 M | 96.11 M | 48.81 M |
| Free CF | -101.2 M | -84.75 M | -85.1 M | -30.23 M |
| Capex | -23.59 M | -12.51 M | -15.46 M | -0.34 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 115.05% | 264.53% | — | — |
| Earnings Growth % | -20.92% | -11.73% | — | — |
| Profit Margin % | -190.28% | -338.39% | -1104.04% | — |
| Operating Margin % | -177.85% | -305.83% | -1054.01% | — |
| Gross Margin % | 40.47% | 1.3% | -139.59% | — |
| EBITDA Margin % | -163.8% | -274.34% | -966.44% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.